In vivo data provide compelling proof-of-concept for Chroma’s epigenetic editing platform to enable highly efficient, specific, and durable gene regulation Data demonstrate the potential of the company’s epigenetic editors for multiplex editing while preserving genomic integrity BOSTON,…